Press Releases

Success of experimental antibody treatment has implications for Lou Gehrig’s disease.

A computerized brain implant relieves short-term and chronic pain in rodents in a new study.

Study is the first to target the innate immune system to treat Alzheimer’s disease in monkeys.

The study used a mathematical tool to assess treatment order for high-grade serous ovarian cancer.

Researchers discovered prototype drugs that promise to strengthen antibiotics.

A $52 million grant from the National Institutes of Health funds the multisite research effort.

Researchers led a clinical trial that finds a new drug can reduce the size of lung tumors.

Researchers caution that lower antibody response does not necessarily mean patients are unprotected.

NYU Langone offers an at-home tDCS Program for virtual, noninvasive brain stimulation.

This is part of an effort to advocate for closing the vaccination gap due to the COVID-19 pandemic.